flow trial semaglutide kidney outcomes nejm 2024 hazard ratio reduced the risk of clinically important and death from cardiovascular (CV) causes in patients with type 2 diabetes (T2D) and CKD ca. #ERA24 🇸🇪 #Nephpearls https://www.nejm .org/doi/full/10.1056/NEJMoa2403347 flow trial semaglutide kidney outcomes

Novo Nordisk's savings card provides up to $500 off per monthly prescription, with a maximum annual benefit

For our Milwaukee community, it's about more than just losing weightit's about gaining energy, improving health markers like blood pressure and cholesterol, and rediscovering the vitality to enjoy life to the fullest

Medicare and Medicaid explicitly exclude weight loss medications from coverage in nearly all states, meaning seniors and low-income patients cannot access Wegovy through public insurance programs

Our providers discuss your eligibility and explain GLP-1 options in detail

Regular monitoring required

Owing to significantly lowered antioxidant capacity, increased demand for energy, and larger levels of lipids/ketones, nervous tissue is particularly prone to oxidative stress [134, 135]